| Api Name | Category | Regulatory Status | India Registration | Formulation |
|---|---|---|---|---|
| Amprolium | Veterinary Drug | - | Available | NA |
| Oxytetracycline Dihydrate | Tetracycline Antibiotic | CEP | Under Registration | Oral, Injection |
| Oxytetracycline Hcl | Tetracycline Antibiotic | CEP | Under Registration | Oral, Injection |
| Streptomycin Sulphate (oral & Sterile) | Aminoglycoside | CEP | Available | Oral, Injection |
| Tiamulin Hydrogen Fumarate | Pleuromutilin Antibiotic | - | Available | Oral |
| Tylosin Tartrate | Macrolide Antibiotic | - | Available | Oral, Injection |
| Tylvalosin Tartrate (vet) | Macrolide Antibiotic | - | Under Registration | Oral |
| Feed Premixes | Feed Premixes |
|---|---|
| Dl-methionine 99% Feed Grade | Nicarbazin – Upto 25% Feed Grade |
| L-threonine 98.5% Feed Grade | Monensin Sodium 20% Premix Feed Grade |
| L-tryptophan 98% Feed Grade | Monensin Sodium 60% Feed Grade |
| L-lysine Monohydrochloride 98% | Decoquinate 6% Feed Grade |
| L-lysine Sulphate 70% Feed Grade | Dinitolmide 25% Feed Grade |
| Chlortetracyclin 15% Feed Grade | Halofuginone 6% Feed Grade |
| Clopidol 25% Feed Grade | Robenidine 10% Premix (Feed Grade) |
| Diclazuril 0.5% Feed Grade | Tiamulin Hydrogen Fumarate 10% Feed Grade |
| Tylosin Phosphate 10% Premix Feed Grade | Lincomycin 11% Feed Premix |
| Maduramycin 1% Feed Grade | Avilamycin 10% Feed Grade |
| Salinomycin 12% Feed Grade | Spectinomycin 22% Feed Premix |
| Emamycin 8% Feed Grade | Betan Hcl 93–98% |
Together, we ensure every product meets the highest global pharmaceutical standards.
Our commitment to quality, compliance, and consistency drives every partnership we build, delivering trusted solutions to markets worldwide.
Name |
Contact Number |
|
|---|---|---|
| Ms Ujwala Parkhe | +91 9702958555 | ujwala.parkhe@rifapharma.com |
Mumbai
Hyderabad
China
Vapi, Gujarat(Warehouse)
+91 9619494942
+91 9702958555
+91 9987776776
Copyright 2022 Rifa Pharma | Designed and Developed By Enliten IT
Connect with our Medical Devices Specialist for product guidance, technical support, and partnership inquiries.
|
Name |
Contact Number |
|
|---|---|---|
| Disha Desai | +91 96194 94942 | disha.desai@rifapharma.com |
Ms. Desai has masterfully elevated the valuation of the Packaging and Medical Devices division, breaking barriers and unlocking new opportunities. She is an invaluable force with over 10+ years of expertise and a portfolio of 30+ customer companies. Her relentless hustle, strategic vision, and unwavering determination not only seize opportunities but create them, driving unprecedented growth and success.
Ms. Ujwala is a razor-sharp professional with an unwavering focus on delivering results. With deep expertise in the veterinary premix market, she ensures every promise and goal is achieved. Her tenacity, proficiency with active ingredients, and strategic foresight set her apart. Leading sales and new developments at Rifa Pharma, she drives innovation, sustainability, and impactful growth, making her a trusted advisor and partner in success.
Our CEO and partner - Dr. Sanjay Loomba, a trauma surgeon and visionary leader, brings over 18 years of expertise in healthcare and the pharmaceutical industry. He has been instrumental in establishing advanced manufacturing facilities and optimising procurement for global markets. Currently, at Rifa Pharma, he focuses on driving innovation, enhancing operational excellence, promoting sustainability, and delivering patient-centric solutions that address the evolving needs of the healthcare sector.
Neha is a dynamic and accomplished leader at Rifa Pharma, bringing over 25 years of expertise in the pharmaceutical industry, with a strong focus on operations. She is highly proficient in business development and regulatory affairs, successfully securing global approvals and driving impactful market expansion. As the Vice Chairperson of the IDMA Bulk Drug Committee, she plays a pivotal role in enhancing industry influence. Her comprehensive expertise extends across corporate governance, ESG strategy, and stakeholder engagement, ensuring sustainable growth and unwavering compliance excellence..
Anant Thakore embodies resilience, vision, and leadership.Stepping in during a critical phase, he revolutionized the company,driving it to a remarkable $60 million indenting enterprise.A true pioneer in India’s pharmaceutical landscape,he played a crucial role in advancing anti-tuberculosis and antibiotic manufacturing. His groundbreaking achievements include becoming the first indigenous manufacturer of corticosteroids,solidifying his legacy as a transformative force in the industry.
